Literature DB >> 23055560

Role of the SP2 domain and its proteolytic cleavage in HIV-1 structural maturation and infectivity.

Alex de Marco1, Anke-Mareil Heuser, Bärbel Glass, Hans-Georg Kräusslich, Barbara Müller, John A G Briggs.   

Abstract

HIV-1 buds as an immature, noninfectious virion. Proteolysis of its main structural component, Gag, is required for morphological maturation and infectivity and leads to release of four functional domains and the spacer peptides SP1 and SP2. The N-terminal cleavages of Gag and the separation of SP1 from CA are all essential for viral infectivity, while the roles of the two C-terminal cleavages and the role of SP2, separating the NC and p6 domains, are less well defined. We have analyzed HIV-1 variants with defective cleavage at either or both sites flanking SP2, or largely lacking SP2, regarding virus production, infectivity, and structural maturation. Neither the presence nor the proteolytic processing of SP2 was required for particle release. Viral infectivity was almost abolished when both cleavage sites were defective and severely reduced when the fast cleavage site between SP2 and p6 was defective. This correlated with an increased proportion of irregular core structures observed by cryo-electron tomography, although processing of CA was unaffected. Mutation of the slow cleavage site between NC and SP2 or deletion of most of SP2 had only a minor effect on infectivity and did not induce major alterations in mature core morphology. We speculate that not only separation of NC and p6 but also the processing kinetics in this region are essential for successful maturation, while SP2 itself is dispensable.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055560      PMCID: PMC3503038          DOI: 10.1128/JVI.01704-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Image reconstructions of helical assemblies of the HIV-1 CA protein.

Authors:  S Li; C P Hill; W I Sundquist; J T Finch
Journal:  Nature       Date:  2000-09-21       Impact factor: 49.962

2.  The stoichiometry of Gag protein in HIV-1.

Authors:  John A G Briggs; Martha N Simon; Ingolf Gross; Hans-Georg Kräusslich; Stephen D Fuller; Volker M Vogt; Marc C Johnson
Journal:  Nat Struct Mol Biol       Date:  2004-06-20       Impact factor: 15.369

Review 3.  Nucleic acid chaperone activity of retroviral Gag proteins.

Authors:  Alan Rein
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 4.  The molecular architecture of HIV.

Authors:  John A G Briggs; Hans-Georg Kräusslich
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

5.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

Review 6.  The role of cellular factors in promoting HIV budding.

Authors:  Eric R Weiss; Heinrich Göttlinger
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

7.  Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1.

Authors:  Lori V Coren; James A Thomas; Elena Chertova; Raymond C Sowder; Tracy D Gagliardi; Robert J Gorelick; David E Ott
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

8.  Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates.

Authors:  Steve C Pettit; Jeffrey N Lindquist; Andrew H Kaplan; Ronald Swanstrom
Journal:  Retrovirology       Date:  2005-11-01       Impact factor: 4.602

9.  Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins.

Authors:  Margareta Cruceanu; Maria A Urbaneja; Catherine V Hixson; Donald G Johnson; Siddhartha A Datta; Matthew J Fivash; Andrew G Stephen; Robert J Fisher; Robert J Gorelick; Jose R Casas-Finet; Alan Rein; Ioulia Rouzina; Mark C Williams
Journal:  Nucleic Acids Res       Date:  2006-01-30       Impact factor: 16.971

10.  HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner.

Authors:  Gilles Mirambeau; Sébastien Lyonnais; Dominique Coulaud; Laurence Hameau; Sophie Lafosse; Josette Jeusset; Isabelle Borde; Michèle Reboud-Ravaux; Tobias Restle; Robert J Gorelick; Eric Le Cam
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

View more
  27 in total

1.  Structure of the immature HIV-1 capsid in intact virus particles at 8.8 Å resolution.

Authors:  Florian K M Schur; Wim J H Hagen; Michaela Rumlová; Tomáš Ruml; Barbara Müller; Hans-Georg Kräusslich; John A G Briggs
Journal:  Nature       Date:  2014-11-02       Impact factor: 49.962

2.  Electron cryotomography studies of maturing HIV-1 particles reveal the assembly pathway of the viral core.

Authors:  Cora L Woodward; Sarah N Cheng; Grant J Jensen
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

3.  Identification of an HIV-1 Mutation in Spacer Peptide 1 That Stabilizes the Immature CA-SP1 Lattice.

Authors:  Juan Fontana; Paul W Keller; Emiko Urano; Sherimay D Ablan; Alasdair C Steven; Eric O Freed
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

4.  Selection of fully processed HIV-1 nucleocapsid protein is required for optimal nucleic acid chaperone activity in reverse transcription.

Authors:  Tiyun Wu; Robert J Gorelick; Judith G Levin
Journal:  Virus Res       Date:  2014-06-20       Impact factor: 3.303

5.  RNA and Nucleocapsid Are Dispensable for Mature HIV-1 Capsid Assembly.

Authors:  Simone Mattei; Annica Flemming; Maria Anders-Össwein; Hans-Georg Kräusslich; John A G Briggs; Barbara Müller
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

6.  Distribution and Redistribution of HIV-1 Nucleocapsid Protein in Immature, Mature, and Integrase-Inhibited Virions: a Role for Integrase in Maturation.

Authors:  Juan Fontana; Kellie A Jurado; Naiqian Cheng; Ngoc L Ly; James R Fuchs; Robert J Gorelick; Alan N Engelman; Alasdair C Steven
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

7.  Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain.

Authors:  Angelica N Martins; Abdul A Waheed; Sherimay D Ablan; Wei Huang; Alicia Newton; Christos J Petropoulos; Rodrigo D M Brindeiro; Eric O Freed
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

8.  Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.

Authors:  Wei Wang; Nada Naiyer; Mithun Mitra; Jialin Li; Mark C Williams; Ioulia Rouzina; Robert J Gorelick; Zhengrong Wu; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

9.  Stability of HIV Frameshift Site RNA Correlates with Frameshift Efficiency and Decreased Virus Infectivity.

Authors:  Pablo Garcia-Miranda; Jordan T Becker; Bayleigh E Benner; Alexander Blume; Nathan M Sherer; Samuel E Butcher
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

10.  Nucleocapsid Protein Precursors NCp9 and NCp15 Suppress ATP-Mediated Rescue of AZT-Terminated Primers by HIV-1 Reverse Transcriptase.

Authors:  Moisés A Árquez; Samara Martín-Alonso; Robert J Gorelick; Walter A Scott; Antonio J Acosta-Hoyos; Luis Menéndez-Arias
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.